| Multiple Sclerosis |
1 |
1 |
| Anxiety |
0 |
0.64 |
| Coronary Artery Disease (CAD) |
0 |
0.23 |
| Arthritis |
0 |
0.21 |
| Autoimmune Disease |
0 |
0.21 |
| Canada |
0 |
0.21 |
| Mental Illness |
0 |
0.21 |
| Multiple Sclerosis Risk |
0 |
0.21 |
| Thyroid |
0 |
0.21 |
| Blood-Brain Barrier |
0 |
0.18 |
| Infectious Mononucleosis |
0 |
0.18 |
| Anxiety Disorder |
0 |
0.13 |
| Adhesion |
0 |
0.11 |
| Blood |
0 |
0.11 |
| Brain |
0 |
0.11 |
| Bullous Pemphigoid |
0 |
0.11 |
| Cancer |
0 |
0.11 |
| Cardiovascular disease |
0 |
0.11 |
| Central Nervous System |
0 |
0.11 |
| Child |
0 |
0.11 |
| Dementia |
0 |
0.11 |
| Disability |
0 |
0.11 |
| Disease Management |
0 |
0.11 |
| Disease-Modifying Therapy |
0 |
0.11 |
| Dorsum |
0 |
0.11 |
| Epstein-Barr Virus |
0 |
0.11 |
| Genetics |
0 |
0.11 |
| Heart |
0 |
0.11 |
| Hyperlipidemia |
0 |
0.11 |
| Immunology |
0 |
0.11 |
| Impairment |
0 |
0.11 |
| Lung |
0 |
0.11 |
| Multiple Sclerosis Relapse |
0 |
0.11 |
| Myelin |
0 |
0.11 |
| Neuroinflammation |
0 |
0.11 |
| Primary Care |
0 |
0.11 |
| Relapsing Remitting Multiple Sclerosis |
0 |
0.11 |
| Vitamin |
0 |
0.11 |
| Migraine |
0 |
0.1 |
| Depression |
0 |
0.09 |
| Thyroid Disease |
0 |
0.09 |
| Cardiovascular Risk Management |
0 |
0.07 |
| Chronic Obstructive Pulmonary Disease |
0 |
0.07 |
| Hypertension |
0 |
0.07 |
| Inflammatory Bowel Disease |
0 |
0.07 |
| Psoriasis |
0 |
0.07 |
| Rheumatoid Arthritis |
0 |
0.07 |
| Cardiometabolic Risk Factors |
0 |
0.06 |
| Genomic Medicine |
0 |
0.06 |
| Obesity |
0 |
0.05 |
| Epilepsy |
0 |
0.04 |
| Herpes Simplex |
0 |
0.04 |
| Obesity in Children |
0 |
0.04 |
| Lipids Management |
0 |
0.02 |